First antigen rapid test for COVID-19 gets Canadian approval
OTTAWA -- Health Canada has given the green light to another rapid test for the virus that causes COVID-19.
The Panbio test from Abbott Rapid Diagnostics in Germany is the first antigen test to be approved in Canada.
Antigen tests look for specific markers on the outside of a virus, while all the tests previously approved in Canada look for the novel coronavirus's genetic material.
The newly approved test can deliver results in 15 minutes, using a nasopharyngeal swab and a device that somewhat resembles a pregnancy test stick.
Abbott's website says the test is accurate at diagnosing a positive case 93 per cent of the time, while negative results are accurate 99 per cent of the time.
This is the fourth test approved by Health Canada that can be completed without sending specimens to a laboratory and is the second that can provide results in 15 minutes or less.
Mia Rabson, The Canadian Press
- Health Canada approves new, rapid mobile test for COVID-19
- Mississauga-based company produces rapid COVID-19 test
- Rapid test for COVID-19 recalled after Health Canada expresses concerns
- Rapid tests slow to be used as health officials unsure of reliability
- Experts warn against negative COVID test as free pass for group socializing
- BREAKING: Canada Post employee dies of COVID-19 following massive outbreak at Mississauga Gateway facility
- Startling study shows people ignore COVID symptoms and continue to work in Mississauga and Brampton
- Furry fear-mongering: Coexisting with coyotes (and other wildlife)
- Ontario pediatricians calling on Province to reopen schools as soon as possible
- 16-year-old charged with attempted murder in Mississauga